Citrine Global Corp. (CTGL)
| Market Cap | 13.05M |
| Revenue (ttm) | 309.98M |
| Net Income (ttm) | -123.60M |
| Shares Out | 1.04B |
| EPS (ttm) | -0.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 116 |
| Open | 0.0125 |
| Previous Close | 0.0125 |
| Day's Range | 0.0125 - 0.0125 |
| 52-Week Range | 0.0050 - 0.0420 |
| Beta | 0.65 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CTGL
Citrine Global Corp. operates as a plant-based wellness and pharma solutions company in Israel. The company focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. It offers SmokLy sprays for cannabis users and tobacco smokers; and DryLess sprays for adult population with constant dry mouth, and other cancer treatment patients with constant dry mouth as part of their cancer treatment regimen. The com... [Read more]
Financial Performance
Financial StatementsNews
Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements' Company with Fast-Growing Potential
Tel Aviv, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that it has signed a binding agreement to acquire up to 51% of the shares of iBOT Israel Botanical...
Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant's Shares against Citrine Global Shares
Tel Aviv, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce the signing of a memorandum of understanding (MOU) with MyPlant Bio Ltd., a pioneering Israeli com...
Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects
Company also Announces the Introduction of GreenFeelsTM Product Lines
Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle
Tel Aviv, July 18, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company's subsidiary, Cannovation Center Israel Ltd, has filed a provisional patent appli...
Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company's Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel
Tel Aviv, May 31, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce Prof. Itamar Grotto joining the Board of Directors of the Company's Israeli subsidiary, Cannovation...
Citrine Global CEO Issues Letter to Shareholders
Tel Aviv, April 13, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL), a plant-based wellness and pharma solutions company, today issued a Letter to Shareholders from its CEO and Chairman, O...
Citrine Global Subsidiary Acquires 11,687 sqm of Industrial Land to Build its 5,500 sqm “Green Vision Center”
Tel Aviv, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp.'s (OTCQB: CTGL) subsidiary, Cannovation Center Israel Ltd. (Cannovation), is pleased to announce that it has acquired 11,687 sqm of ind...
Citrine Global Corp.'s (OTCQB: CTGL) Subsidiary, Cannovation Center Israel Ltd., is Pleased to Announce the Launch of its "Green Side by Side" Products Line and the Signing of an Agreement with Intelicanna to Sell the Products in Israel
Tel Aviv, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp.'s (OTCQB: CTGL) subsidiary, Cannovation Center Israel Ltd. (Cannovation), announced that it has launched its "Green Side by Side" produ...
Citrine Global Subsidiary Files in the U.S. Patent & Trademark Office a Provisional Patent Application for “PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF SIDE EFFECTS ASSOCIATED WITH THE USE OF CANNABIS & RELATED PRODUCTS”
Tel Aviv, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) is pleased to announce that its subsidiary, Cannovation Center Israel Ltd., has filed in the U.S. Patent & Trademark Off...
Citrine Global Subsidiary Enters into Manufacturing Agreement for the Green Botanicals Product Line
Tel Aviv, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) is pleased to announce that its subsidiary, Cannovation Center Israel Ltd., has entered into a manufacturing agreement w...
Mr. Hagai Hillman Joins Cannovation Center Israel Ltd. as a CEO Bringing with Him Decades of Experience and Proven Track Record in the Pharma, Botanical and Medical Cannabis Industries
Tel Aviv, May 05, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) is pleased to announce that Mr. Hagai Hillman has been appointed as a chief executive officer of Canno...
Citrine Global, Corp. (OTCQB: CTGL) announces that the loan provided to Intelicanna Ltd. (TASE: INTL) in July 2020 under the loan agreement entered between the parties, has been repaid.
Tel-Aviv, April 05, 2021 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) is pleased to update that on March 31, 2021 the loan of NIS 500 thousand extended to Intelicanna by ...